Exercise Training In Athletes With Heart Disease

Progress in Cardiovascular Diseases

Volumn 60, Issue 1, 2017, Pages 121-129

  Fernandez, Antonio B ^a   Thompson, Paul D ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

Atherosclerosis; Congenital cardiac disease; Coronary artery disease; Exercise; Exercise training; Hypertrophic cardiomyopathy; Myocardial infarction; Physical activity athlete; Sudden cardiac death

Indexed keywords

ACUTE HEART INFARCTION; AORTIC DISEASE; ATHEROSCLEROSIS; ATHLETE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; ENDURANCE; EXERCISE; HEART DISEASE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MARFAN SYNDROME; PHYSICAL ACTIVITY; REVIEW; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SUDDEN CARDIAC DEATH;

EID: 85019349586     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2017.05.004     Document Type: Review

References (71)

1. Running USA. http://www.runningusa.org/statistics [Accessed November 5, 2016].
2. Eijsvogels, T.M.H., Thompson, P.D., Exercise is medicine: at any dose?. JAMA 341 (2015), 1915–1916.
3. Mann, S., Beedie, C., Jimenez, A., Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med 44 (2014), 211–221.
4. Mora, S., Cook, N., Buring, J.E., Ridker, P.M., Lee, I.M., Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 116 (2007), 2110–2118.
5. Szostak, J., Laurant, P., The forgotten face of regular physical exercise: a ‘natural’ anti-atherogenic activity. Clin Sci (Lond) 121 (2011), 91–106.
6. Joyner, M.J., Nose, H., Physiological regulation linked with physical activity and health. J Physiol 587 (2009), 5525–5526.
7. Rai, M., Thompson, P., The definition of exertion-related cradiac events. Br J Sports Med 45 (2011), 130–131.
8. Albert, C.M., Mittleman, M.A., Chae, C.U., Lee, I.M., Hennekens, C.H., Manson, J.E., Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 343 (2000), 1355–1361.
9. Hallqvist, J., Moller, J., Ahlbom, A., Diderichsen, F., Reuterwall, C., deFaire, U., Does heavy physical exercise trigger myocardial infarction? A case-crossover analysis nested in a population-based case-referent study. Am J Epidemiol 151 (2000), 459–467.
10. Parker, M.W., Thompson, P.D., Assessment and management of atherosclerosis in the athletic patient. Prog Cardiovasc Dis 54 (2012), 416–422.
11. Marijon, E., Uy-Evanado, A., Reinier, K., et al. Sudden cardiac arrest during sports activity in middle age. Circulation 131 (2015), 1384–1391.
12. Maron, B.J., Haas, T.S., Ahluwalia, A., Rutten-Ramos, S.C., Incidence of cardiovascular sudden deaths in Minnesota high school athletes. Heart Rhythm 10 (2013), 374–377.
13. Thompson, P.D., Funk, E.J., Carleton, R.A., Sturner, W.Q., Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 247 (1982), 2535–2538.
14. Maron, B.J., Sudden death in young athletes. N Engl J Med 349 (2003), 1064–1075.
15. Maron, B.J., Doerer, J.J., Haas, T.S., Tierney, D.M., Mueller, F.O., Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 119 (2009), 1085–1092.
16. Maron, B.J., Thompson, P.D., Ackerman, M.J., et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on nutrition, physical activity, and metabolism: endorsed by the American College of Cardiology Foundation. Circulation, 115, 2007, 1643-455.
17. Harmon, K.G., Asif, I.M., Klossner, D., Drezner, J.A., Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 123 (2011), 1594–1600.
18. Maron, B.J., Estes, N.A. III, Commotio cordis. N Engl J Med 362 (2010), 917–927.
19. Burke, A.P., Farb, A., Malcom, G.T., Liang, Y., Smialek, J.E., Virmani, R., Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 281 (1999), 921–926.
20. Kim, J.H., Malhotra, R., Chiampas, G., et al. Cardiac arrest during long-distance running races. N Engl J Med 366 (2012), 130–140.
21. Mittleman, M.A., Maclure, M., Tofler, G.H., Sherwood, J.B., Goldberg, R.J., Muller, J.E., Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of myocardial infarction onset study investigators. N Engl J Med 329 (1993), 1677–1683.
22. Pelliccia, A., Maron, B.J., Di Paolo, F.M., et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 46 (2005), 690–696.
23. Sorokin, A.V., Araujo, C.G., Zweibel, S., Thompson, P.D., Atrial fibrillation in endurance-trained athletes. Br J Sports Med 45 (2011), 185–188.
24. Mohlenkamp, S., Lehmann, N., Breuckmann, F., et al. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 29 (2008), 1903–1910.
25. La Gerche, A., Burns, A.T., Mooney, D.J., et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 33 (2012), 998–1006.
26. Maron, B.J., Pelliccia, A., The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 114 (2006), 1633–1644.
27. Andersen, K., Farahmand, B., Ahlbom, A., et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J 34 (2013), 3624–3631.
28. Myrstad, M., Nystad, W., Graff-Iversen, S., et al. Effect of years of endurance exercise on risk of atrial fibrillation and atrial flutter. Am J Cardiol 114 (2014), 1229–1233.
29. Thompson, P.D., Physical fitness, physical activity, exercise training, and atrial fibrillation: first the good news, then the bad. J Am Coll Cardiol 66 (2015), 997–999.
30. Pathak, R.K., Elliott, A., Middeldorp, M.E., et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol 66 (2015), 985–996.
31. Douglas, P.S., O'Toole, M.L., Hiller, W.D., Reichek, N., Different effects of prolonged exercise on the right and left ventricles. J Am Coll Cardiol 15 (1990), 64–69.
32. La Gerche, A., Heidbuchel, H., Burns, A.T., et al. Disproportionate exercise load and remodeling of the athlete's right ventricle. Med Sci Sports Exerc 43 (2011), 974–981.
33. James, C.A., Bhonsale, A., Tichnell, C., et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 62 (2013), 1290–1297.
34. Schwartz, R.S., Merkel-Kraus, S., Schwartz, J.G., et al. Increased coronary artery plaque volume among male marathon runners. Mo Med 111 (2014), 85–90.
35. Hutchinson, A., The Runner's heart. 2016, Runner's World, 77–86.
36. Barry, D.W., Kohrt, W.M., Acute effects of 2 hours of moderate-intensity cycling on serum parathyroid hormone and calcium. Calcif Tissue Int 80 (2007), 359–365.
37. Criqui, M.H., Denenberg, J.O., Ix, J.H., et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 311 (2014), 271–278.
38. Kirchhof, P., Fabritz, L., Zwiener, M., et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114 (2006), 1799–1806.
39. Cruz, F.M., Sanz-Rosa, D., Roche-Molina, M., et al. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J Am Coll Cardiol 65 (2015), 1438–1450.
40. Maron, B.J., Zipes, D.P., Kovacs, R.J., Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66 (2015), 2343–2349.
41. Ballantyne, C.M., Raichlen, J.S., Nicholls, S.J., et al. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation 117 (2008), 2458–2466.
42. Anderson, L., Oldridge, N., Thompson, D.R., et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 67 (2016), 1–12.
43. Berger, T., Brenneis, C., Alber, H., Is RAMIT reflecting the real world?. Heart, 99, 2013, 1137.
44. Keteyian, S.J., Hibner, B.A., Bronsteen, K., et al. Greater improvement in cardiorespiratory fitness using higher-intensity interval training in the standard cardiac rehabilitation setting. J Cardiopulm Rehabil Prev 34 (2014), 98–105.
45. Thompson, P.D., Myerburg, R.J., Levine, B.D., Udelson, J.E., Kovacs, R.J., Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 8: coronary artery disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66 (2015), 2406–2411.
46. Zhao, X.Q., Dong, L., Hatsukami, T., et al. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging 4 (2011), 977–986.
47. Murdoch, J.L., Walker, B.A., Halpern, B.L., Kuzma, J.W., McKusick, V.A., Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 286 (1972), 804–808.
48. Campens, L., Renard, M., Trachet, B., et al. Intrinsic cardiomyopathy in Marfan syndrome: results from in-vivo and ex-vivo studies of the Fbn1C1039G/+ model and longitudinal findings in humans. Pediatr Res 78 (2015), 256–263.
49. D'Andrea, A., Cocchia, R., Riegler, L., et al. Aortic root dimensions in elite athletes. Am J Cardiol 105 (2010), 1629–1634.
50. Parish, L.M., Gorman, J.H. III, Kahn, S., et al. Aortic size in acute type a dissection: implications for preventive ascending aortic replacement. Eur J Cardiothorac Surg 35 (2009), 941–945 [discussion 945-6].
51. Chubb, H., Simpson, J.M., The use of Z-scores in paediatric cardiology. Ann Pediatr Cardiol 5 (2012), 179–184.
52. Reed, C.M., Richey, P.A., Pulliam, D.A., Somes, G.W., Alpert, B.S., Aortic dimensions in tall men and women. Am J Cardiol 71 (1993), 608–610.
53. Shores, J., Berger, K.R., Murphy, E.A., Pyeritz, R.E., Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 330 (1994), 1335–1341.
54. Habashi, J.P., Doyle, J.J., Holm, T.M., et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332 (2006), 361–365.
55. Gott, V.L., Gillinov, A.M., Pyeritz, R.E., et al. Aortic root replacement. Risk factor analysis of a seventeen-year experience with 270 patients. J Thorac Cardiovasc Surg 109 (1995), 536–544 [discussion 544-5].
56. Price, J., Magruder, J.T., Young, A., et al. Long-term outcomes of aortic root operations for Marfan syndrome: a comparison of Bentall versus aortic valve-sparing procedures. J Thorac Cardiovasc Surg 151 (2015), 330–336.
57. Maron, B.J., Ommen, S.R., Semsarian, C., Spirito, P., Olivotto, I., Maron, M.S., Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 64 (2014), 83–99.
58. Maron, M.S., Maron, B.J., Clinical Impact of contemporary cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy. Circulation 132 (2015), 292–298.
59. Chan, R.H., Maron, B.J., Olivotto, I., et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130 (2014), 484–495.
60. Galderisi, M., Cardim, N., D'Andrea, A., et al. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 16, 2015, 353.
61. Maron, B.J., Rowin, E.J., Casey, S.A., et al. Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies. J Am Coll Cardiol 65 (2015), 1915–1928.
62. Maron, B.J., Ackerman, M.J., Nishimura, R.A., Pyeritz, R.E., Towbin, J.A., Udelson, J.E., Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 45 (2005), 1340–1345.
63. Pelliccia, A., Fagard, R., Bjornstad, H.H., et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study Group of Sports Cardiology of the working Group of Cardiac Rehabilitation and Exercise Physiology and the working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26 (2005), 1422–1445.
64. Maron, B.J., Haas, T.S., Murphy, C.J., Ahluwalia, A., Rutten-Ramos, S., Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 63 (2014), 1636–1643.
65. Gersh, B.J., Maron, B.J., Bonow, R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 124 (2011), e783–e831.
66. Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., Thiene, G., Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 (2003), 1959–1963.
67. Maron, B.J., Historical perspectives on sudden deaths in young athletes with evolution over 35 years. Am J Cardiol 116 (2015), 1461–1468.
68. Alpert, C., Day, S.M., Saberi, S., Sports and exercise in athletes with hypertrophic cardiomyopathy. Clin Sports Med 34 (2015), 489–505.
69. Reineck, E., Rolston, B., Bragg-Gresham, J.L., et al. Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. Am J Cardiol 111 (2013), 1034–1039.
70. Eijsvogels, T.M., Molossi, S., Lee, D.C., Emery, M.S., Thompson, P.D., Exercise at the extremes: the amount of exercise to reduce cardiovascular events. J Am Coll Cardiol 67 (2016), 316–329.
71. Levine, B.D., Baggish, A.L., Kovacs, R.J., Link, M.S., Maron, M.S., Mitchell, J.H., Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 1: classification of sports: dynamic, static, and Impact: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66 (2015), 2350–2355.